Tradestie Institutional Equity Comparison Engine

PVLA vs DSGN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PVLA Overall Edge

PVLA Captures Institutional Edge (2โ€“1 Pillars ยท 2โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Palvella Therapeutics, Inc. Common Stock (PVLA) driven by superior Momentum & Technical, Options & Structure while DSGN counters with relative strength in Growth & Margin. Fundamentally, PVLA trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus DSGN at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, PVLA sits in CONSOLIDATION (2nd %ile IV; Dealer Gamma Walls on Pro) against DSGN sits in BREAKDOWN (13th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
PVLA N/M vs DSGN N/M Fwd P/E
Growth & Margin Winner DSGN
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner PVLA
1Y +80.2% vs +40.8% ยท 52W Pos 68% vs 30%
Options & Structure Winner PVLA
CONSOLIDATION (2nd %ile IV) vs BREAKDOWN (13th %ile IV)
PVLA NASDAQ
Palvella Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$145.03
-4.89% 1D
Market Cap $2.2B
1M Return +20.56%
1Y Return +80.16%
Forward P/E N/M
Unified AI Score
48.9 / 100 HOLD
Tech 38.0 Fund 52.0 Flow 67.0 Mom 60.0
DSGN NASDAQ
Design Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$9.94
-5.06% 1D
Market Cap $677.5M
1M Return -3.59%
1Y Return +40.79%
Forward P/E N/M
Unified AI Score
49.8 / 100 HOLD
Tech 55.0 Fund 57.0 Flow 63.0 Mom 54.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: PVLA +80.16% DSGN +40.79% Spread: +39.37 pp (PVLA Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period PVLA Revenue DSGN Revenue PVLA Op. Margin DSGN Op. Margin Margin Edge
FY2016 $10M N/A -390.3% N/A PVLA
FY2017 $30M N/A -57.7% N/A PVLA
FY2018 $30M N/A -113.1% N/A PVLA
FY2019 $40M N/A -62.2% N/A PVLA
FY2020 $30M $0M -115.7% -3685.8% PVLA
FY2021 $30M N/A -165.0% N/A PVLA
FY2022 $30M N/A -167.8% N/A PVLA
FY2023 $40M N/A -27.7% N/A PVLA

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: PVLA (2) vs DSGN (3)
Institutional Metric PVLA DSGN Criterion Row Winner
Market Capitalization Scale $2.2B $677.5M Larger Scale PVLA
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +0.0% Higher Growth Tie
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -63.4% -36.9% Higher ROE DSGN
52-Week Range Position Momentum 68% ($72โ€“$180) 30% ($7โ€“$17) Stronger Trend PVLA
Beta / 30D Volatility Risk Regime 1.66ฮฒ ยท 75% Vol 1.32ฮฒ ยท 61% Vol Lower Realized Risk DSGN
Unified Institutional Score Composite Signal 48.9 / 100 (HOLD) 49.8 / 100 (HOLD) Higher Composite DSGN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full PVLA vs DSGN Buy Guide
PVLA CONSOLIDATION
70d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 2nd %ile
IV Regime Compressed (<25th %ile)
Live PVLA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
DSGN BREAKDOWN
139d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 13th %ile
IV Regime Compressed (<25th %ile)
Live DSGN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither PVLA nor DSGN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.